CLAIM: A video of Pfizer CEO Albert Bourla at a World Economic Forum conference in Davos, Switzerland, shows him explaining new Pfizer technology, a pill with a sensor that alerts “relevant authorities” when digested.
AP’S ASSESSMENT: False. The 2018 video shows Bourla was referring to a pill that had been developed by a separate company and approved by the U.S. Food and Drug Administration months prior. The pill, which includes an ingestible sensor to digitally track whether patients take their medication, is used to treat people with schizophrenia, bipolar I disorder and major depressive disorder.
THE FACTS: Social media users are sharing a video of Bourla talking about ingestible sensors at the World Economic Forum in 2018 out of context to falsely suggest the CEO was discussing technology that could be used for surveillance during the COVID-19 pandemic.
“Pfizer CEO Albert Bourla explains Pfizer’s new tech to Davos crowd: ‘ingestible pills’ – a pill with a tiny chip that send a wireless signal to relevant authorities when the pharmaceutical has been digested. ‘Imagine the compliance,’ he says,” read one tweet, dropping the s on send.
Bourla was discussing a pill that the FDA approved in November 2017. The drug, Abilify MyCite, developed by Otsuka Pharmaceutical Co. and Proteus Digital Health, has an ingestible sensor that notifies doctors when the medication has been taken.
Pfizer has no relationship to the pill that’s manufactured by Otsuka, a spokesperson for the company said.
“The video circulating was taken before the COVID-19 pandemic, and Albert was speaking about a medicine for schizophrenia that was approved by the FDA,” Jerica Pitts, a representative for Pfizer, told The Associated Press in an email. “There is no evidence that Pfizer’s COVID-19 antiviral pills or vaccine contains microchips.”
Read the rest:
From ingestible sensors and AI-assisted doctors to healthcare that is affordable and accessible to all, how are technologies shaping the future of healthcare?
Dimensions to be addressed: – Informatics, artificial intelligence and robotics – Next-generation imaging technologies – Patient-centric and tech-enabled care ·
Albert Bourla, Chief Operating Officer, Pfizer, USA · Satya Nadella, Chief Executive Officer, Microsoft Corporation, USA · Michael F. Neidorff, Chairman and Chief Executive Officer, Centene Corporation, USA · Rajeev Suri, President and Chief Executive Officer, Nokia Corporation, Finland
Moderated by · Rebecca Blumenstein, Deputy Managing Editor, New York Times, USA http://www.weforum.org/